Use of inhaled antibiotics among Danish patients with cystic fibrosis.

"CONFLICTS OF INTEREST Tavs Qvist has received a research grant from Chiesi Pharmaceutici (20,000 EUR) for the purpose of financing salary for the PI of the study. Tavs Qvist has received unrelated grants from Rigshospitalets Research Council (250,000 EUR), The Danish CF Foundation: (42,000 EUR), and University of Queensland FORMAT Trial (26,000 EUR). Honorarium for educational activities outside the submitted work from the Chiesi Group (2000 EUR). Personal fees for lectures, scientific steering committee work or review from The Belgian CF Foundation (200 EUR), AstraZenica A/S (1075 EUR), Vertex (4317 EUR). Personal fees from Advisory Board outside the submitted work: Vertex (3558 EUR), Zambon Netherlands (3000 EUR), Chiesi Group (1300 EUR). The remaining authors declare no conflicts of interest."

"The authors would like to thank patients and staff at the Copenhagen Cystic Fibrosis Center. This study was supported by a grant from Chiesi Pharmaceutici, including funding of Rikke Møller's (PI) salary. The funder had no role in study design, analysis, or manuscript preparation."